This session is organized by GLOBE – Global Life Sciences Opportunities Business Exchange, an Intellectual Exchange Group with the North Carolina Biotechnology Center. GLOBE partners include the U.S.

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Califf completed his second term as FDA commissioner in January with the change in administrations. He’s only the second ...

In an all-digital world, how can a more hands-on, personalized marketing and sales approach be leveraged to strengthen human connections?Come to this talk and discover how a personal touch can take ...

Any bioscience or other technology company in North Carolina that has received a specified type of federal grant for research and development has until Dec. 1 to apply for matching state funds through ...

Around the world, small businesses have taken a hit during the COVID-19 pandemic. Life sciences companies have been challenged on a personal and professional level, facing the same economic crisis as ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug Administration to resume clinical testing of a potential therapy for type 1 ...

Republished with permission from Andersen Sterilizers News. See this story for more on the Andersen impact on North Carolina's life sciences scene. In the spring of 2020, Carl May was graduating high ...

The North Carolina Biotechnology Center’s Piedmont Triad Office is welcoming seven new thought leaders to its regional advisory committee. The new committee members from unique backgrounds and ...

Chapel Hill-based Path BioAnalytics (PBA) has joined forces with Australian researchers to study a new drug to fight SARS-related Coronoavirus-2, the virus that causes COVID-19. Researchers at Recce ...

Burlington-based LabCorp has launched a new test that it says may be helpful in battling the COVID-19 pandemic. The test is a neutralizing antibody assay that assesses the capacity of antibodies in ...

Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy. Researchers at North Carolina ...